Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. - Wikidata - awgldk - TriplyDB

Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.

Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.

http://www.wikidata.org/entity/Q35001593

about

Cord blood graft engineering Counteracting the enzymatic activity of dipeptidylpeptidase 4 for potential therapeutic advantage, with an emphasis on cord blood transplantation Stem Cells: Potential Therapy for Neonatal Injury?Preclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo.Umbilical cord blood transplantation: the first 25 years and beyond.Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cells Is there an expiration date for a cord blood unit in storage?The role and potential of umbilical cord blood in an era of new therapies: a review Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment.A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.Impact of long-term cryopreservation on single umbilical cord blood transplantation outcomes.Placenta-based therapies for the treatment of epidermolysis bullosa Postthaw characterization of umbilical cord blood: markers of storage lesion Mild Heat Treatment Primes Human CD34(+) Cord Blood Cells for Migration Toward SDF-1α and Enhances Engraftment in an NSG Mouse Model Impact of maternal and neonatal factors on parameters of hematopoietic potential in umbilical cord blood Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation Tip110 maintains expression of pluripotent factors in and pluripotency of human embryonic stem cells Alternative blood products and clinical needs in transfusion medicine Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell lines.Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype A review of factors influencing the banking of collected umbilical cord blood units Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types.Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis.MiR-31/SDHA Axis Regulates Reprogramming Efficiency through Mitochondrial Metabolism Stem cells: a personal perspective.Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs).Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction.Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming.Long-Term Quality Control Program Plan for Cord Blood Banks in Korea: A Pilot Study for Cryopreservation Stability.Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors.The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors.Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotype Quality of cord blood cryopreserved for up to 5 years.Clinical utilization of cord blood over human health: experience of stem cell transplantation and cell therapy using cord blood in Korea.Promise and challenges of human iPSC-based hematologic disease modeling and treatment.Generation of mature hematopoietic cells from human pluripotent stem cells.Current thawing and infusion practice of cryopreserved cord blood: the impact on graft quality, recipient safety, and transplantation outcomes.

P2860

Q26822376-C6E9781C-CB49-413C-A629-AC93345C5EE7 Q27012935-EC4D212A-4FCB-40C4-BCEB-678AB042784A Q28082268-B96C59C0-B791-4841-92E8-03DA2E5E6AFD Q33722449-03D42349-DA91-4F65-AB13-3367F680969E Q34344669-CCE1AE10-D070-47B9-A473-547AEED01A15 Q34443020-8ECB4F97-7D63-4F43-89EE-188B9E8CD3E6 Q34449885-1BBF55ED-B2EE-45F6-A359-7479E3E4D953 Q34483172-740B409B-842E-49D4-9084-71B3366DDFEC Q34533929-E893F197-EB5B-492B-A856-6B8500AF5DE8 Q35200170-9900A673-4A46-4515-8998-02E138847A61 Q35230664-E576947B-5AC8-4466-B937-D6AF0347EABB Q35582332-7752B009-00AE-4D4F-B38C-9A671AE19C3A Q35598071-C880D958-4A5F-41D4-A216-39C0E910BE34 Q35637523-461A09B6-60AE-4E75-8BEA-FDCB26DA9A1F Q35681181-C71FAA96-A82A-44B4-B41F-F1DE4DF741AB Q35822337-4A21BAFE-B2CF-470C-8351-B571BBF01599 Q35861728-C03479B9-4A47-4839-B8EC-C4C05F8FCD4B Q35915095-46721A8D-59D6-4390-929E-4EFF457DB45D Q36138514-3B7A9AB4-1AB5-4762-8468-502B496BC36F Q36192813-4C9C7B4D-1BA6-4B87-96E1-BAC6F8965656 Q36286847-8EA3DF3A-EAEB-4AFD-9DDA-A9E8119E0A8B Q36692414-3CF350B5-B64D-4363-9E67-C7E5AB4B9E64 Q36984624-DE77C693-1B2B-4A45-879D-B8B154DE1E17 Q37006880-95293719-CF22-4C38-A7C1-595F27036C91 Q37014686-3AD3D68E-AA91-464F-8823-4A8D24F77FAA Q37092134-A136CCCA-3C85-41D4-B34F-89FE69F986FF Q37094169-5A2CF97F-5BA8-47FC-98DE-BAD8E26F0D4F Q37181597-4C69F80B-98DA-41BA-8677-876963C10B2B Q37265783-A3078155-E330-4850-8C6D-A602039EFDF2 Q37353891-533846AE-0B69-4DCD-BE4F-44C77571FCBB Q37523278-3097E894-C41E-4160-A940-5992B7959AE3 Q37547770-24B2F5C6-A85C-420F-9729-161D5B196A33 Q37562037-1C78C4CE-39F8-44A0-9004-039FA0A70538 Q37602425-0C53D55A-BEE2-429A-B545-53B785110186 Q37617110-7B9E354D-9E83-4A91-A11B-54E211351CF6 Q37683269-61E594C0-2EBE-436C-AE17-1A9D5065209A Q37725142-E6B6034F-515B-4895-B29A-3D4D7E228CA9 Q38012401-21C85D97-059C-4503-B7AE-04950D235BD4 Q38014778-061EB6D5-D97C-42E6-AC92-53FD72C6254C Q38217398-2A5D7356-6EC3-4492-A8A4-D6B38530D478

P2860

Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.

http://www.wikidata.org/entity/Q35001593

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Hematopoietic stem/progenitor ...... year cryopreserved cord blood.

@ast

Hematopoietic stem/progenitor ...... year cryopreserved cord blood.

@en

type

label

Hematopoietic stem/progenitor ...... year cryopreserved cord blood.

@ast

Hematopoietic stem/progenitor ...... year cryopreserved cord blood.

@en

prefLabel

Hematopoietic stem/progenitor ...... year cryopreserved cord blood.

@ast

Hematopoietic stem/progenitor ...... year cryopreserved cord blood.

@en

P1433

Q35001593-37208097-3424-4926-A471-F932DBFF12BB

P1476

Q35001593-0FE9F86D-A461-484A-9FCC-AE10C0777CA2

P2093

Q35001593-01F8360B-54E7-4980-A5E9-913A95FD47FA

Q35001593-0F253186-8521-4A4A-856F-F0F491F8BF09

Q35001593-17C7B0FD-87B0-489C-9C9B-441B971AB4C9

Q35001593-23892827-0F99-4F78-A1F3-31F06E5A3414

Q35001593-24867C5B-1BDD-4102-A342-9EC8F6F4F3E6

Q35001593-600AD1EA-DB82-469B-8326-EEF16DF27766

Q35001593-7F400298-D758-469A-A34D-9CBB2A3AA407

Q35001593-8E385040-2335-4654-84D8-64270FD42B95

Q35001593-935F1627-477D-41A8-9342-1EDC5027ECCD

Q35001593-CF1791D8-09BE-42B1-B6A7-B20032BB59CE

P2860

Q35001593-31359B7A-1409-4400-80B1-70AF5FB1DC75

Q35001593-43C7E785-3A0A-472C-A297-0313D7A40AC4

Q35001593-53226A8A-FAAE-44B1-9310-27E9143A902D

Q35001593-6305C08E-DC8B-4C0E-A2E7-5502F1B0AC68

Q35001593-7D5E3D7E-8094-4AFC-B7E2-44B47770F7E4

Q35001593-7F7242ED-296B-4B8A-B096-8A67A0434782

Q35001593-94F41EC6-DCD1-4B2A-91AB-F89356B415F3

Q35001593-9E19B29F-B895-471C-9770-547FC7A0A18E

Q35001593-A5A4578E-5DD7-4E89-8903-5DE02A87985F

Q35001593-A8D0B269-A73D-47C1-87DF-AB5C6C9451E2

P304

Q35001593-6DC6C9EA-E157-4B5B-817D-334021D1D782

P31

Q35001593-947DF2EB-8B7D-4B34-A303-30027F48B224

P356

Q35001593-48D7821D-CA05-42AF-A597-E0BEF2444433

P407

Q35001593-C9F21C55-7268-4B2C-93D7-2FDDACF4023E

P433

Q35001593-13EA6D94-A981-4483-8C4C-56C3055C85E7

P478

Q35001593-D456E44A-6511-490B-828C-63B375B19943

P50

Q35001593-F1922384-1647-4EE3-A3FE-953579508C6D

P577

Q35001593-57BFDE82-B919-47C6-9B7A-D8276F6C76BE

P5875

Q35001593-A2AE2909-919E-4854-B1E9-CA23F2DCB0F7

P698

Q35001593-2AE6367E-3BEF-400B-8AA3-57138D3E45B0

P921

Q35001593-51057881-EF57-453E-9D18-3047E1ED02B6

Q35001593-BE64C5AF-FFA2-4322-8350-8E5748729363

P932

Q35001593-75435D35-3A08-491E-853C-6CEF1C732D01

P356

BLOOD-2011-01-330514

P1433

P1476

Hematopoietic stem/progenitor ...... year cryopreserved cord blood.

@en

P2093

Coleen Mallett

http://www.w3.org/2001/XMLSchema#string

Giao Hangoc

http://www.w3.org/2001/XMLSchema#string

Hal E Broxmeyer

http://www.w3.org/2001/XMLSchema#string

Kenneth Cornetta

http://www.w3.org/2001/XMLSchema#string

Man-Ryul Lee

http://www.w3.org/2001/XMLSchema#string

Mervin C Yoder

http://www.w3.org/2001/XMLSchema#string

Nutan Prasain

http://www.w3.org/2001/XMLSchema#string

Scott Cooper

http://www.w3.org/2001/XMLSchema#string

Scott Witting

http://www.w3.org/2001/XMLSchema#string

Young-June Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders

Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years.

Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling.

Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability.

T-lymphocyte recovery and function after cord blood transplantation.

Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies

Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.

P304

4773-4777

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-01-330514

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50363849

http://www.w3.org/2001/XMLSchema#string

P698

21393480

http://www.w3.org/2001/XMLSchema#string

P921

cryopreservation

P932

3100689

http://www.w3.org/2001/XMLSchema#string